Tony M. Korman

9.6k total citations
157 papers, 5.1k citations indexed

About

Tony M. Korman is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Tony M. Korman has authored 157 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Epidemiology, 75 papers in Infectious Diseases and 34 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Tony M. Korman's work include Antimicrobial Resistance in Staphylococcus (34 papers), Bacterial Identification and Susceptibility Testing (31 papers) and Streptococcal Infections and Treatments (25 papers). Tony M. Korman is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (34 papers), Bacterial Identification and Susceptibility Testing (31 papers) and Streptococcal Infections and Treatments (25 papers). Tony M. Korman collaborates with scholars based in Australia, United Kingdom and New Zealand. Tony M. Korman's co-authors include Despina Kotsanas, Benjamin P. Howden, Paul D. R. Johnson, Sally Roberts, John Turnidge, Rhonda L. Stuart, Andrew Fuller, M. Lindsay Grayson, Patrick G. P. Charles and M. Lindsay Grayson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Tony M. Korman

152 papers receiving 5.0k citations

Peers

Countries citing papers authored by Tony M. Korman

Since Specialization

Citations

This map shows the geographic impact of Tony M. Korman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony M. Korman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony M. Korman more than expected).

Fields of papers citing papers by Tony M. Korman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony M. Korman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony M. Korman. The network helps show where Tony M. Korman may publish in the future.

Co-authorship network of co-authors of Tony M. Korman

This figure shows the co-authorship network connecting the top 25 collaborators of Tony M. Korman. A scholar is included among the top collaborators of Tony M. Korman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony M. Korman. Tony M. Korman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment‐resistant tinea caused by Trichophyton indotineae in Australia 2024 ·The Medical Journal of Australia ·Kyra Chua, Catriona Halliday, Sharon C.‐A. Chen, Sonia Koning, (unknown), Philipp du Cros, Tony M. Korman	5
2	Use of echinocandin outpatient parenteral antimicrobial therapy for the treatment of infection caused by Candida spp.: utilization, outcomes and impact of a change to weekly dosing 2024 ·Journal of Antimicrobial Chemotherapy ·(unknown), A. Grenfell, (unknown), Helen Richards, Tony M. Korman, Benjamin A. Rogers	1
3	Clostridioides difficileInfection: Clinical Practice and Health Outcomes in 6 Large Tertiary Hospitals in Eastern Australia 2023 ·Open Forum Infectious Diseases ·Adam G. Stewart, Sharon C.-A. Chen, Kate Hamilton, Tiffany Harris‐Brown, Tony M. Korman, Melanie Figtree, Leon J. Worth, Jen Kok, David van der Poorten, Karen Byth, Monica A. Slavin, David L. Paterson	0
4	Comparison of contemporary invasive and non-invasive Streptococcus pneumoniae isolates reveals new insights into circulating anti-microbial resistance determinants 2023 ·Antimicrobial Agents and Chemotherapy ·Charlie Higgs, (unknown), Kerrie Stevens, Janet Strachan, Tony M. Korman, Kristy Horan, Diane Daniel, (unknown), Christopher A. McDevitt, Norelle L. Sherry, Timothy P. Stinear, Benjamin P. Howden, Claire L. Gorrie	4
5	Corrigendum to : Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV 2022 ·Sexual Health ·(unknown), Ian Woolley, (unknown), Tony M. Korman, Georgia Soldatos	1
6	Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient 2021 ·Infection Control and Hospital Epidemiology ·(unknown), Gareth P. Gregory, Anna Pierce, Julian Druce, Mike Catton, (unknown), Norelle L. Sherry, Maryza Graham, Melissa Chen, (unknown), (unknown), Jean Lee, Zoe McQuilten, Simon Crouch, Clare Looker, Tony M. Korman, Rhonda L. Stuart	4
7	Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015–18 2021 ·Journal of Antimicrobial Chemotherapy ·Papanin Putsathit, (unknown), Narelle George, (unknown), (unknown), Tony M. Korman, Despina Kotsanas, Monica M Lahra, Rodney McDougall, (unknown), (unknown), Graeme R. Nimmo, (unknown), Jennifer Robson, Lynette Waring, Michael C. Wehrhahn, Gerhard F. Weldhagen, Richard Wilson, Thomas V. Riley, Daniel R. Knight	16
8	Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in Humans 2020 ·ACS Sensors ·(unknown), Rodrigo Curvello, (unknown), (unknown), Julia A. Walker, Samuel Leguizamon, (unknown), Vikram Singh Raghuwanshi, (unknown), Erica M. Wood, Zoe McQuilten, Maryza Graham, (unknown), Tony M. Korman, Timothy F. Scott, Mark M. Banaszak Holl, Gil Garnier, Simon R. Corrie	23
9	Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia 2020 ·Infection Control and Hospital Epidemiology ·Norelle L. Sherry, Robyn S. Lee, Claire L. Gorrie, Jason C. Kwong, Rhonda L. Stuart, Tony M. Korman, Caroline Marshall, Charlie Higgs, Hiu Tat Chan, Maryza Graham, Paul D.R. Johnson, (unknown), (unknown), Michael J. Richards, Monica A. Slavin, Leon J. Worth, Benjamin P. Howden, M. Lindsay Grayson	15
10	Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis 2018 ·Nature Microbiology ·Jean Lee, Ian R. Monk, Anders Gonçalves da Silva, Torsten Seemann, Kyra Chua, Angela Kearns, (unknown), Neil Woodford, Mette Damkjær Bartels, Birgit Strommenger, Frédéric Laurent, Magali Dodémont, A. Deplano, Robin Patel, Anders Rhod Larsen, Tony M. Korman, Timothy P. Stinear, Benjamin P. Howden	211
11	Herpes simplex virus‐2 transmission following solid organ transplantation: Donor‐derived infection and transplantation from prior organ recipients 2017 ·Transplant Infectious Disease ·Nenad Maćešić, Iain J. Abbott, Matthew Kaye, Julian Druce, Allan R. Glanville, Paul Gow, Peter Hughes, Tony M. Korman, William R. Mulley, (unknown), Helen Opdam, Miranda Paraskeva, Matthew C. Pitman, (unknown), William D. Rawlinson, Paul D. R. Johnson	12
12	Improved standardization and potential for shortened time to results with BD Kiestra™ total laboratory automation of early urine cultures: A prospective comparison with manual processing 2016 ·Diagnostic Microbiology and Infectious Disease ·Maryza Graham, (unknown), (unknown), (unknown), Tony M. Korman	27
13	Bacteroides pyogenes causing serious human wound infection from animal bites 2016 ·Anaerobe ·Jillian S. Y. Lau, Tony M. Korman, (unknown), (unknown), Michelle Francis, Maryza Graham	14
14	Disseminated Enteroviral Infection Associated with Obinutuzumab 2015 ·Emerging infectious diseases ·Claire Dendle, Michael Gilbertson, Tony M. Korman, Vera Golder, Eric F. Morand, Stephen Opat	16
15	Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia 2013 ·Clinical Microbiology and Infection ·Natasha E. Holmes, John Turnidge, Wendy Munckhof, James O. Robinson, Tony M. Korman, Matthew O’Sullivan, Theodore L. Anderson, Sally Roberts, (unknown), Wei Gao, Paul D. R. Johnson, Benjamin P. Howden	18
16	Community acquired bacteraemia in patients over the age of 60: A two year retrospective review 2011 ·Internal Medicine Journal ·Sara Barnes, (unknown), Despina Kotsanas, Alison Beauchamp, Tony M. Korman, Donald Campbell	1
17	The Dominant Australian Community-Acquired Methicillin-Resistant Staphylococcus aureus Clone ST93-IV [2B] Is Highly Virulent and Genetically Distinct 2011 ·PLoS ONE ·Kyra Chua, Torsten Seemann, Paul F. Harrison, (unknown), Tony M. Korman, Paul D. R. Johnson, Geoffrey W. Coombs, Brian O. Howden, John K. Davies, Benjamin P. Howden, Timothy P. Stinear	73
18	ASID/TSANZ guidelines: Treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents 2009 ·The Medical Journal of Australia ·Allen Cheng, Dominic E. Dwyer, Tom Kotsimbos, Michael Starr, Tony M. Korman, (unknown), Christine Jenkins, Vicki Krause, Paul D. R. Johnson	10
19	The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis 1999 ·Journal of Antimicrobial Chemotherapy ·Karin Leder, John Turnidge, Tony M. Korman, M. Lindsay Grayson	58
20	FatalLegionella longbeachae infection following heart transplantation 1998 ·European Journal of Clinical Microbiology & Infectious Diseases ·Tony M. Korman, (unknown), (unknown), David M. Kaye, Peter Bergin	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact